[Drug-induced changes in allergic mediatory reactivity in constitutional neurodermatitis patients].
D000109:Acetylcholine / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D000368:Aged; D001920:Bradykinin / Q000494:pharmacology; D002648:Child; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004336:Drug Antagonism; D004342:Drug Hypersensitivity / Q000503:physiopathology; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology* / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy / Q000276:immunology*; D010919:Placebos; D012701:Serotonin / Q000494:pharmacology; D012871:Skin Diseases / Q000188:drug therapy / Q000276:immunology; D012882:Skin Tests; D014966:Xanthenes / Q000494:pharmacology* / Q000627:therapeutic use
D003879:Dermatologic Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010919:Placebos; D014966:Xanthenes; D012701:Serotonin; D006632:Histamine; D000109:Acetylcholine; D001920:Bradykinin
Medikamentös bedingte Veränderungen der allergisch-mediatorischen Reaktivität bei Neurodermitis-constitutionalis-Kranken.